Mersana Therapeutics Inc (MRSN) — Capital Reinvestment Ratio
Mersana Therapeutics Inc (MRSN) has a Capital Reinvestment Ratio of 0.01x as of September 2022, meaning it reinvests 0% of its operating cash flow ($54.60 Million) in capital expenditures ($426.00K). See Mersana Therapeutics Inc balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Mersana Therapeutics Inc Capital Reinvestment Ratio (2016–2016)
This chart tracks Mersana Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check Mersana Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Mersana Therapeutics Inc (2016–2016)
Year-by-year Capital Reinvestment Ratio for Mersana Therapeutics Inc from 2016 to 2016. For live market cap and broader valuation context, see market value of Mersana Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.03x | $31.59 Million | $1.08 Million | — |